Invention Grant
- Patent Title: Anti-glucagon receptor antibodies and pharmaceutical compositions thereof
- Patent Title (中): 抗胰高血糖素受体抗体及其药物组合物
-
Application No.: US14268933Application Date: 2014-05-02
-
Publication No.: US09248189B2Publication Date: 2016-02-02
- Inventor: Alison Jane Forgie , Javier Fernando Chaparro Riggers , Edward Roland Lavallie , Chia-Yang Lin , Lidia Mosyak , Andrea Rossi , Thomas John Van Blarcom
- Applicant: RINAT NEUROSCIENCE CORP.
- Applicant Address: US NY New York
- Assignee: PFIZER INC.
- Current Assignee: PFIZER INC.
- Current Assignee Address: US NY New York
- Main IPC: A61K45/06
- IPC: A61K45/06 ; A61K31/155 ; A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
The present invention provides antagonizing antibodies that bind to glucagon receptor and methods of using same. The anti-glucagon receptor antibodies can be used therapeutically to lower glucose levels in blood, and can be in the prevention and/or treatment of glucose-related disorders, including diabetes, hyperglycemia, hyperinsulinemia, impaired fasting glucose, impaired glucose tolerance, dyslipidemia, or metabolic syndrome.
Public/Granted literature
- US20140335091A1 ANTI-GLUCAGON RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF Public/Granted day:2014-11-13
Information query
